A Unique MicroRNA Signature Associated With Plaque Instability in Humans

Background and Purpose— Atherosclerotic plaque rupture is considered the most important mechanism that underlies the onset of stroke, myocardial infarction, and sudden death. Several evidences demonstrated the pivotal role of inflammatory processes in plaque destabilization. MicroRNAs (miRNAs) are small endogenous RNAs and represent a new important class of gene regulators. Nevertheless, no data exist about the expression profile of miRNAs in atherosclerotic plaques. Thus, the aim of this study was to investigate the expression level of miRNAs in human plaques and to correlate it with clinical features of plaque destabilization. Methods— Two separate groups of plaques were collected from patients who underwent carotid endarterectomy in Chieti (n=15) and Ancona (n=38) Hospitals. All the plaques were subdivided in symptomatic (n=22) and asymptomatic (n=31) according to the presence/absence of stroke. Results— First, on the plaques collected at Chieti Hospital, we performed large-scale analysis of miRNA expression. Between the 41 miRNAs examined, we discovered profound differences in the expression of 5 miRNAs (miRNA-100, miRNA-127, miRNA-145, miRNA-133a, and miRNA-133b) in symptomatic versus asymptomatic plaques. Remarkably, when we repeated the analysis on the Ancona plaque subset, all these 5 miRNAs confirmed to be significantly more expressed in the symptomatic plaques. Finally, in vitro experiments on endothelial cells transfected with miRNA-145 and miRNA-133a confirmed the importance of these miRNAs in the modulation of stroke-related proteins. Conclusions— These results are the first to report alterations in the expression of specific miRNAs in human atherosclerotic plaques and suggest that miRNAs may have an important role in regulating the evolution of atherosclerotic plaque toward instability and rupture. Furthermore, by identifying the specific miRNA signature for stroke now, we are able to use computer algorithms to identify previously unrecognized molecular targets.

[1]  M. Latronico,et al.  Emerging role of microRNAs in cardiovascular biology. , 2007, Circulation research.

[2]  V. Kim.  MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.

[3]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[4]  John Bracht,et al.  MicroRNAs: a developing story. , 2005, Current opinion in genetics & development.

[5]  R. Aharonov,et al.  Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.

[6]  S. Tyagi,et al.  MicroRNAs as a therapeutic target for cardiovascular diseases , 2009, Journal of cellular and molecular medicine.

[7]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[8]  A. Buchan,et al.  *North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. North American Symptomatic Carotid Endarterectomy Trial Methods, Patients Characteristics and Progress. , 1991 .

[9]  Mark A Sussman,et al.  The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits , 2006, Circulation research.

[10]  P. D. de Tombe,et al.  Intracellular Localization and Functional Effects of P21-Activated Kinase-1 (Pak1) in Cardiac Myocytes , 2004, Circulation research.

[11]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[12]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[13]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[14]  G. Pellegrini,et al.  Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: Association with increased nitric oxide synthase expression and superoxide anion generation , 2003, Journal of cellular physiology.

[15]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[16]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[17]  P. Rothberg,et al.  Oncogenes and cancer. , 1983, Cancer investigation.

[18]  V. Ambros.  MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.

[19]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[20]  J. Mendell,et al.  MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.

[21]  C. Reutelingsperger,et al.  Imaging apoptosis for detecting plaque instability: rendering death a brighter facade. , 2007, Current opinion in biotechnology.

[22]  Chunxiang Zhang,et al.  MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation , 2009, Circulation research.

[23]  George A Calin,et al.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. , 2007, The Journal of clinical investigation.

[24]  Kunio Inoue.  [MicroRNA function in animal development]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[25]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[26]  L. Wilkins.  North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. , 1991, Stroke.

[27]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[28]  C. Burge,et al.  The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.

[29]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[30]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[31]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[32]  G. Niccoli,et al.  High telomerase activity in neutrophils from unstable coronary plaques. , 2007, Journal of the American College of Cardiology.

[33]  P. Zamore,et al.  MicroRNAs: Regulating a Change of Heart , 2009, Circulation.

[34]  Chaoqian Xu,et al.  The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes , 2007, Journal of Cell Science.

[35]  Peter Libby,et al.  Vascular biology of atherosclerosis: overview and state of the art. , 2003, The American journal of cardiology.

[36]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[37]  Giuseppe Rainaldi,et al.  miRNAs Regulate miRNAs: Coordinated Transcriptional and Post-Transcriptional Regulation , 2006, Cell cycle.